Cynosure Appoints William T. Kelley as Senior Vice President of International Sales
February 25 2009 - 8:30AM
PR Newswire (US)
Laser Industry Executive to Head Company's Network of International
Subsidiaries and Distributors WESTFORD, Mass., Feb. 25
/PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ: CYNO), a leading
developer and manufacturer of a broad array of light-based
aesthetic treatment systems, today announced the appointment of
William T. Kelley as Senior Vice President of International Sales.
He will be responsible for the company's direct subsidiaries in
four European countries, Japan, China and Korea, and for Cynosure
distributors covering an additional 55 countries. "Bill brings more
than 25 years of experience in the medical device industry and a
track record of success in growing a global distribution
organization," said Michael Davin, Cynosure's President and Chief
Executive Officer. "Bill has extensive background in the aesthetic
and surgical laser market, and is an ideal choice to help us expand
the reach of our aesthetic products around the world." Since 2004
Kelley was director of international sales at Sciton Inc., a
privately held aesthetic device company based in Palo Alto,
California, where he was responsible for all business activity
outside the United States. Prior to that he served as vice
president and general manager for Asclepion-Meditec Inc., the
surgical laser division of international optics leader Carl Zeiss
AG. As vice president of worldwide sales and marketing for Summit
Technology, a maker of ophthalmic excimer laser systems, he
supervised the company's direct sales forces in the United States,
the United Kingdom and Scandinavia as well as distributors in other
regions. From 1985 to 1991 he was general manager of Pfizer Laser
Systems, the surgical laser division of Pfizer Corp. "Cynosure has
worked hard to build its base of direct subsidiaries, expanding its
overseas distribution network and establishing its brand as a
standard of quality in more than 60 countries," Kelley said. "I am
excited about the opportunity to guide its international
organization and to help execute on Cynosure's strategic plan for
financial and operational success." About Cynosure, Inc. Cynosure,
Inc. develops and markets aesthetic treatment systems that are used
by physicians and other practitioners to perform non-invasive and
minimally invasive procedures to remove hair, treat vascular and
pigmented lesions, rejuvenate the skin, liquefy and remove unwanted
fat through laser lipolysis and temporarily reduce the appearance
of cellulite. Cynosure's products include a broad range of laser
and other light-based energy sources, including Alexandrite, pulsed
dye, Nd:YAG and diode lasers, as well as intense pulsed light.
Cynosure was founded in 1991. For corporate or product information,
contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. Safe Harbor Any statements in this press
release about future expectations, plans and prospects for
Cynosure, Inc., including statements about the company's
expectations and future financial performance, as well as other
statements containing the words "believes," "anticipates," "plans,"
"expects," "will" and similar expressions, constitute
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995. Actual results may differ
materially from those indicated by such forward-looking statements
as a result of various important factors, including Cynosure's
reliance on sole source suppliers, the inability to accurately
predict the timing or outcome of regulatory decisions, changes in
consumer preferences, competition in the aesthetic laser industry,
economic, market, technological and other factors discussed in
Cynosure's most recent Annual Report on Form 10-K, which is filed
with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure
anticipates that subsequent events and developments will cause its
views to change. However, while Cynosure may elect to update these
forward-looking statements at some point in the future, it
specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing Cynosure's views as of any date subsequent to the date
of this press release. Contact Scott Solomon Vice President Sharon
Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc.
CONTACT: Scott Solomon, Vice President of Sharon Merrill
Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web Site:
http://www.cynosure.com/
Copyright